1. Home
  2. LOAN vs FBIO Comparison

LOAN vs FBIO Comparison

Compare LOAN & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOAN
  • FBIO
  • Stock Information
  • Founded
  • LOAN 1989
  • FBIO 2006
  • Country
  • LOAN United States
  • FBIO United States
  • Employees
  • LOAN N/A
  • FBIO N/A
  • Industry
  • LOAN Real Estate Investment Trusts
  • FBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • LOAN Real Estate
  • FBIO Health Care
  • Exchange
  • LOAN Nasdaq
  • FBIO Nasdaq
  • Market Cap
  • LOAN 61.5M
  • FBIO 58.3M
  • IPO Year
  • LOAN 1999
  • FBIO N/A
  • Fundamental
  • Price
  • LOAN $5.49
  • FBIO $1.81
  • Analyst Decision
  • LOAN
  • FBIO Strong Buy
  • Analyst Count
  • LOAN 0
  • FBIO 2
  • Target Price
  • LOAN N/A
  • FBIO $21.00
  • AVG Volume (30 Days)
  • LOAN 23.8K
  • FBIO 214.8K
  • Earning Date
  • LOAN 07-22-2025
  • FBIO 08-12-2025
  • Dividend Yield
  • LOAN 8.42%
  • FBIO N/A
  • EPS Growth
  • LOAN N/A
  • FBIO N/A
  • EPS
  • LOAN 0.48
  • FBIO N/A
  • Revenue
  • LOAN $7,300,469.00
  • FBIO $57,784,000.00
  • Revenue This Year
  • LOAN N/A
  • FBIO $51.59
  • Revenue Next Year
  • LOAN $4.47
  • FBIO $44.74
  • P/E Ratio
  • LOAN $11.44
  • FBIO N/A
  • Revenue Growth
  • LOAN N/A
  • FBIO N/A
  • 52 Week Low
  • LOAN $4.74
  • FBIO $1.33
  • 52 Week High
  • LOAN $6.05
  • FBIO $2.36
  • Technical
  • Relative Strength Index (RSI)
  • LOAN 53.57
  • FBIO 41.92
  • Support Level
  • LOAN $5.40
  • FBIO $1.90
  • Resistance Level
  • LOAN $5.54
  • FBIO $2.02
  • Average True Range (ATR)
  • LOAN 0.17
  • FBIO 0.09
  • MACD
  • LOAN -0.01
  • FBIO -0.02
  • Stochastic Oscillator
  • LOAN 42.30
  • FBIO 15.38

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Share on Social Networks: